|
L2HGDH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04209996187876E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56260054579627E-10 |
| Normal-vs-Stage2 |
1.83010000043282E-07 |
| Normal-vs-Stage3 |
1.73580000373263E-08 |
| Normal-vs-Stage4 |
1.86880999999417E-05 |
| Stage1-vs-Stage2 |
9.652000E-01 |
| Stage1-vs-Stage3 |
6.407600E-01 |
| Stage1-vs-Stage4 |
6.292000E-01 |
| Stage2-vs-Stage3 |
7.336800E-01 |
| Stage2-vs-Stage4 |
7.364200E-01 |
| Stage3-vs-Stage4 |
5.157200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.62710022811564E-10 |
| Normal-vs-AfricanAmerican |
2.60191868051152E-12 |
| Normal-vs-Asian |
1.797770E-03 |
| Caucasian-vs-AfricanAmerican |
7.823400E-01 |
| Caucasian-vs-Asian |
8.451400E-01 |
| AfricanAmerican-vs-Asian |
9.371000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.62700030804342E-10 |
| Normal-vs-Female |
2.01659999810033E-09 |
| Male-vs-Female |
5.208600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.3727996517332E-10 |
| Normal-vs-Extreme_Weight |
1.19710019674812E-10 |
| Normal-vs-Obese |
2.94580004833733E-09 |
| Normal-vs-Extreme_Obese |
1.624660E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.209600E-01 |
| Normal_Weight-vs-Obese |
1.375170E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.038200E-02 |
| Extreme_Weight-vs-Obese |
4.853900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.897420E-01 |
| Obese-vs-Extreme_Obese |
3.317400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.07890000267119E-08 |
| Normal-vs-Age(41-60Yrs) |
1.54220003434347E-09 |
| Normal-vs-Age(61-80Yrs) |
5.72569991419414E-10 |
| Normal-vs-Age(81-100Yrs) |
1.41090000005395E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.544000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.613800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.789800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.604000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.469600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.96560023602422E-10 |
| Normal-VS-Type2 PRCC |
2.14794848574229E-12 |
| Normal-VS-KIRP CIMP |
3.50120000000009E-05 |
| Normal-VS-Unclassified PRCC |
8.27659996094354E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.936200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.594000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.665400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.650600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.803600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.015200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75430003857002E-10 |
| Normal-vs-N1 |
1.85989999956782E-07 |
| Normal-vs-N2 |
4.01769728597401E-11 |
| N0-vs-N1 |
3.822400E-01 |
| N0-vs-N2 |
9.272200E-02 |
| N1-vs-N2 |
1.175850E-03 |
|
|
